Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 31246229

Denosumab vs Zoledronic Acid for Bone-Targeted Therapy in Multiple Myeloma: What Are the Unanswered Questions?

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
JAMA Oncol
Publication date
2019 Aug 1
First author
Chakraborty R

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Chakraborty R
      type
      Author
    2. name
      Majhail NS
      type
      Author
    3. name
      Anwer F
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Chakraborty R
      type
      Author
    2. name
      Majhail NS
      type
      Author
    3. name
      Anwer F
      type
      Author
    bibliography ids
    1. nci-bib-e13edf8462ce3bc346059fdf
    book metadata
    content sha256
    b074c4939fd96c14e27f9e0151620809c52ba5cef64b736f121b02a5be0d824f
    document type
    citation
    dois
    1. 10.1001/jamaoncol.2019.1598
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:31246229
    immutable id
    pubmed:31246229@b074c4939fd96c14e27f9e0151620809c52ba5cef64b736f121b02a5be0d824f
    journal
    abbreviation
    JAMA Oncol
    issn electronic
    2374-2445
    issn print
    2374-2437
    issue
    8
    name
    JAMA oncology
    nlm unique id
    101652861
    pages
    1095-1096
    volume
    5
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      31246229
      provenance
      batch id
      23ffe1e2a9e160b6dca0
      provider
      NCBI PubMed ESummary
      record sha256
      f5c494e9ff7bad05515494526271c90697a01448792c71cbe07538d5b2787f9e
      response sha256
      d5cbfde8f87ba85b214c53aaf0e8fa33d70fec48dd4fde7745538180cd7e1841
      retrieved at
      2026-09-09T23:47:44.690737+00:00
      publication date
      display
      2019 Aug 1
      precision
      day
      year
      2019
      publication types
      1. Journal Article
      record status
      PubMed
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/31246229/
      title
      Denosumab vs Zoledronic Acid for Bone-Targeted Therapy in Multiple Myeloma: What Are the Unanswered Questions?

      Preserved source evidence · Not medical advice